U.S. overdose deaths attributed to synthetic opioids, such as fentanyl, have increased from under 3,000 in 2013 to nearly 20,000 in 2016, making up half of all opioid-related overdose deaths. These drugs are often purchased ...
Oct 9, 2019
0
1
Less than 5 percent of state drug pricing laws passed between 2015 and 2018 will provide new information about pricing within the pharmaceutical distribution system. The rest of the laws passed either do not focus on transparency ...
Oct 3, 2019
0
11
President Trump has called for ways to allow U.S. residents to buy cheaper prescription drugs from Canada. Many drugs are cheaper in Canada, thanks to government price controls in that country.
Oct 2, 2019
0
4
Compared with large chains, independent pharmacies and small chains had the highest cash prices for generic drugs and big-box pharmacies the lowest. Cash prices for brand-name drugs were similar across all types of retail ...
Oct 1, 2019
0
2
Putting her stamp on the health care issue that worries consumers the most, House Speaker Nancy Pelosi on Thursday unveiled an ambitious plan to lower drug prices for seniors on Medicare and younger people with private insurance.
Sep 19, 2019
0
1
When bidding in a competitive market, brains use a special type of heuristic to adjust the price depending on the success of previous attempts to buy goods. Moreover, this learning mechanism involves not only the cerebral ...
Sep 18, 2019
0
2
Demand for prescription medications in the U.S. is at an all time high, given that 50% of adults have at least one chronic condition, and 25% have two or more. Sixty percent of the population, and 90% of Medicare beneficiaries ...
Sep 11, 2019
0
2
Medicare often spends $3,590 for an individual's 30-day prescription after adjusting for all rebates, and prices continue to rise.
Sep 5, 2019
0
12
Taxing high sugar snacks such as biscuits, cakes, and sweets might be more effective at reducing obesity levels than increasing the price of sugar sweetened drinks, suggests a study published by The BMJ today.
Sep 4, 2019
1
309
Over the course of a decade, out-of-pocket costs for multiple sclerosis drugs rose more than sevenfold for Medicare Part D beneficiaries, according to a JAMA Neurology study published today by researchers at the University ...
Aug 26, 2019
0
4
